Learn how cloud-based QMS improves security, data integrity, and compliance.
Message below is a paid advertisement. Content is provided by the sponsor.

The Tufts Center for the Study of Drug Development (Tufts CSDD), an academic group affiliated with the Tufts University Medical School, will conduct a study on how drug development sponsors gather and report cardiac safety assessments supporting their clinical trial activity.

Tufts CSDD greatly values your responses to this important survey, which should take no longer than 20 minutes to complete, and will share the summary results with you as a 'Thank You' for participating. Tufts CSDD will also make a donation to a charity you select (American Heart Association, CISCRP, or Eupati), to be chosen at the end of the survey. Please note that all responses are confidential and will be reported in the aggregate.

To participate in the study as a sponsor, click here.

To participate as a site, click here.


If you are no longer interested in receiving updates from Tufts CSDD, you can unsubscribe instantly

Tufts Center for the Study of Drug Development
75 Kneeland Street, Suite 1100, Boston, MA 02111

You received this email because you are a customer of ACT, a UBM publication. You are on the mailing list as %%emailaddress%%.